Discover the top 31 companies transforming the digital PCR and qPCR market, including Danaher Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., and other industry leaders. Backed by a market projected to grow from $10.0B to $14.8B by 2029 at a CAGR of 8.1%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry. Access the full market research report for deeper insights.
Download PDF Brochure:“Click Here”
Spotlights on the Industry’s Top Digital PCR Companies
Danaher Corporation
Danaher Corporation is a global science and technology innovator that maintains a significant presence in the digital PCR market through its life sciences segment. The company focuses on providing high-precision genomic solutions and molecular diagnostic tools, leveraging its extensive portfolio of reagents and instruments to support clinical and research applications worldwide.
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. is a major player in the digital PCR industry, recently launching the Digital LightCycler System to enhance diagnostics in oncology and infectious diseases. The company specializes in developing next-generation systems that offer high sensitivity for detecting rare genetic mutations, further solidifying its leadership in personalized medicine and clinical research.
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a leading provider of digital PCR technology, notably with its Applied Biosystems QuantStudio Absolute Q Digital PCR System. The company offers fully integrated workflows designed for speed and precision, catering to a wide range of applications including cell and gene therapy, oncology research, and environmental monitoring.
Merck KGaA
Merck KGaA is an established global leader in life sciences that provides critical consumables, reagents, and instruments for the digital PCR market. The company’s offerings support a broad spectrum of genomic research and diagnostic workflows, emphasizing high-quality biological materials and innovative analytical tools.
Qiagen N.V.
Qiagen N.V. is a prominent provider of sample-to-insight solutions, widely recognized for its QIAcuity digital PCR platform. The company has expanded its market reach through strategic collaborations, such as with the FBI for forensic applications, and continues to develop specialized assay kits for cell therapy and infectious disease detection.
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. is a pioneer in the digital PCR space, best known for its Droplet Digital PCR (ddPCR) technology, including the QX Continuum and QX700 systems. Through strategic acquisitions like Stilla Technologies, the company has reinforced its role in precision diagnostics and high-throughput genetic analysis.
Agilent Technologies, Inc.
Agilent Technologies, Inc. provides advanced analytical solutions and genomic tools that support the digital PCR market. The company focuses on delivering high-performance instruments and software that enable laboratories to achieve accurate results in clinical diagnostics, environmental testing, and academic research.
Takara Bio Inc.
Takara Bio Inc. is a specialized biotechnology company that offers a comprehensive range of PCR reagents and genomic research tools. Within the digital PCR market, the company provides high-quality enzymes and kits essential for precise nucleic acid quantification and advanced molecular biology applications.
Becton, Dickinson and Company
Becton, Dickinson and Company (BD) is a global medical technology firm that integrates digital PCR capabilities into its broader molecular diagnostics and life sciences portfolio. The company focuses on improving clinical outcomes by providing innovative tools for pathogen detection and high-sensitivity genetic testing.
Abbott Laboratories
Abbott Laboratories is a major healthcare company that utilizes digital PCR technology within its molecular diagnostics division to enhance disease monitoring and patient care. Its involvement in the market is characterized by a focus on high-precision testing solutions for infectious diseases and oncology.
Promega Corporation
Promega Corporation provides foundational biochemical reagents and integrated systems for the digital PCR market. The company has engaged in strategic co-marketing agreements, such as with Stilla Technologies, to combine its sample preparation expertise with advanced digital PCR workflows for improved laboratory efficiency.
Meridian Bioscience
Meridian Bioscience specializes in the development and manufacture of innovative diagnostic tests and essential reagents for the PCR market. The company supports the digital PCR ecosystem by providing high-performance master mixes and enzymes designed for the absolute quantification of DNA and RNA.
Endress+Hauser Group Services AG
Endress+Hauser Group Services AG contributes to the digital PCR market through its involvement in life sciences and laboratory instrumentation. The company provides specialized technology and services that support the precision and reliability required for advanced molecular analysis and process control.
bioMérieux
bioMérieux is a world leader in in vitro diagnostics that incorporates digital PCR technology into its efforts to combat infectious diseases and improve public health. The company focuses on delivering high-impact diagnostic solutions that provide rapid and precise results for clinical laboratories globally.
Eppendorf AG
Eppendorf AG is a leading life science company that develops and sells instruments, consumables, and services for liquid, sample, and cell handling. In the digital PCR market, the company provides the high-precision laboratory hardware and consumables necessary for accurate partitioning and sample preparation.
QuidelOrtho Corporation
QuidelOrtho Corporation is a prominent provider of innovative diagnostic solutions that utilize digital PCR to enhance point-of-care and clinical laboratory testing. The company’s portfolio focuses on high-sensitivity assays for infectious diseases, supporting early detection and effective patient management.
Enzo Biochem Inc.
Enzo Biochem Inc. is an integrated life sciences and diagnostics company that provides specialized labeling and detection technologies for digital PCR applications. The company offers a range of proprietary reagents and assays used in research and clinical settings to identify biomarkers and genetic mutations.
Lepu Medical Technology Co., Ltd.
Lepu Medical Technology Co., Ltd. is a global medical device company that has expanded into the molecular diagnostics sector, including digital PCR. The company develops cost-effective and high-precision PCR platforms and kits aimed at improving diagnostic accessibility and patient monitoring in various healthcare settings.
Sysmex Corporation
Sysmex Corporation is a leading diagnostic company that has invested in digital PCR technology to advance personalized medicine and liquid biopsy. Through its innovation in high-sensitivity genetic analysis, the company provides tools that assist in the early detection and monitoring of cancer and other complex diseases.
Biocartis
Biocartis is an innovative molecular diagnostics company that focuses on providing rapid and easy-to-use testing solutions. In the digital PCR market, the company aims to streamline complex genomic workflows, making high-precision genetic testing more accessible to clinical laboratories and hospitals.
Stilla
Stilla is a biotechnology leader known for its Crystal Digital PCR technology and the Naica system. The company specializes in high-multiplexing and high-sensitivity digital PCR solutions, supported by a strong global distribution network and strategic partnerships with industry leaders like Bio-Rad and Promega.
Antylia Scientific
Antylia Scientific is a global leader in life sciences and diagnostic products, providing critical equipment and consumables that support digital PCR workflows. The company focuses on delivering reliable tools for sample preparation and analysis, ensuring precision in diverse research and clinical applications.
Bioneer Corporation
Bioneer Corporation is a South Korean biotechnology company that offers a comprehensive range of molecular biology products, including digital PCR systems and reagents. The company is recognized for its vertical integration, developing both the hardware and the chemical components required for advanced nucleic acid quantification.
Standard BioTools
Standard BioTools, formerly Fluidigm, provides high-capacity genomics instruments like the X9 Real-Time PCR System and various digital PCR solutions. The company focuses on microfluidic technology to enable high-throughput, efficient, and precise analysis for research in genomics, oncology, and immunology.
Seegene Inc.
Seegene Inc. is a global leader in multiplex molecular diagnostics that utilizes digital PCR technology to enhance its syndromic testing capabilities. The company’s innovative approach allows for the simultaneous detection of multiple pathogens, providing comprehensive results for infectious disease management.
GenScript
GenScript is a leading biotech company providing life science research services and products, including custom assays and reagents for digital PCR. The company supports the market by offering high-quality synthetic nucleic acids and specialized tools that facilitate advanced genomic and proteomic research.
LGC Biosearch Technologies
LGC Biosearch Technologies provides mission-critical components and specialized reagents for the digital PCR market. The company is a key supplier of high-quality primers, probes, and enzymes, supporting the accuracy and reliability of molecular diagnostic tests and genomic research worldwide.
QuantaBio
QuantaBio is a leading supplier of high-performance PCR reagents and master mixes designed for demanding applications in digital PCR. The company focuses on developing robust and sensitive chemistries that ensure consistent results in absolute quantification and rare mutation detection.
Randox Laboratories Ltd.
Randox Laboratories Ltd. is a global diagnostics company that incorporates digital PCR into its extensive portfolio of clinical and research testing solutions. The company provides innovative molecular diagnostic kits and platforms aimed at improving the accuracy of disease diagnosis and patient monitoring.
New England Biolabs
New England Biolabs is a world leader in the discovery and production of enzymes for molecular biology. In the digital PCR market, the company provides essential high-purity enzymes and reagents that are critical for the successful amplification and quantification of nucleic acids in partitioned samples.
PCR Biosystems
PCR Biosystems is a specialist manufacturer of high-quality PCR reagents and master mixes tailored for digital PCR applications. The company focuses on developing advanced chemistries that offer superior sensitivity and market-leading performance for both research and diagnostic laboratories.
Download PDF Brochure:“Click Here”
